These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8263533

  • 1. [3H]GBR-12935 binding to human cerebral cortex is not to dopamine uptake sites.
    Allard P, Danielsson M, Papworth K, Marcusson JO.
    J Neurochem; 1994 Jan; 62(1):338-41. PubMed ID: 8263533
    [Abstract] [Full Text] [Related]

  • 2. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO, Eriksson K, Ross SB, Marcusson JO.
    Neuropsychobiology; 1994 Jan; 23(4):177-81. PubMed ID: 2130286
    [Abstract] [Full Text] [Related]

  • 3. [3H]GBR-12935 binding to cytochrome P450 in the human brain.
    Allard P, Marcusson JO, Ross SB.
    J Neurochem; 1994 Jan; 62(1):342-8. PubMed ID: 8263534
    [Abstract] [Full Text] [Related]

  • 4. [3H]GBR-12935 binding to dopamine uptake sites in the human brain.
    Marcusson J, Eriksson K.
    Brain Res; 1988 Aug 02; 457(1):122-9. PubMed ID: 3167558
    [Abstract] [Full Text] [Related]

  • 5. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK.
    Brain Res; 1991 Feb 01; 540(1-2):1-13. PubMed ID: 1829013
    [Abstract] [Full Text] [Related]

  • 6. Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935.
    Reith ME, Selmeci G.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar 01; 345(3):309-18. PubMed ID: 1620235
    [Abstract] [Full Text] [Related]

  • 7. [3H]GBR 12935 binding to dopamine uptake sites in the human brain.
    De Keyser J, De Backer JP, Ebinger G, Vauquelin G.
    J Neurochem; 1989 Nov 01; 53(5):1400-4. PubMed ID: 2795007
    [Abstract] [Full Text] [Related]

  • 8. Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways.
    Izenwasser S, Werling LL, Rosenberger JG, Cox BM.
    Neuropharmacology; 1990 Nov 01; 29(11):1017-24. PubMed ID: 2087254
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex.
    Andersen PH.
    J Neurochem; 1987 Jun 01; 48(6):1887-96. PubMed ID: 2952763
    [Abstract] [Full Text] [Related]

  • 18. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
    Niznik HB, Tyndale RF, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, Kalow W.
    Arch Biochem Biophys; 1990 Feb 01; 276(2):424-32. PubMed ID: 2306106
    [Abstract] [Full Text] [Related]

  • 19. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.
    Janowsky A, Berger P, Vocci F, Labarca R, Skolnick P, Paul SM.
    J Neurochem; 1986 Apr 01; 46(4):1272-6. PubMed ID: 3081686
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.